Table 1 Analysis of FBG at the baseline, 6 weeks, and 12 weeks
Evaluation variable | Groups | Baseline | 6 weeks | 12 weeks | p value |
|---|---|---|---|---|---|
Glucose (ITT) | Placebo | 110.4 ± 8.9 | 111.9 ± 14.6 | 110.7 ± 15.5 | 0.504 |
CLM | 113.6 ± 9.9 | 106.3 ± 12.8 | 105.9 ± 14.0 | ||
Glucose (PP) | Placebo | 110.7 ± 9.1 | 111.8 ± 14.8 | 110.8 ± 16.0 | 0.492 |
CLM | 113.4 ± 10.3 | 106.8 ± 13.1 | 107.2 ± 15.1 |